Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14760324rdf:typepubmed:Citationlld:pubmed
pubmed-article:14760324lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:14760324lifeskim:mentionsumls-concept:C0021368lld:lifeskim
pubmed-article:14760324lifeskim:mentionsumls-concept:C0948089lld:lifeskim
pubmed-article:14760324lifeskim:mentionsumls-concept:C0016017lld:lifeskim
pubmed-article:14760324lifeskim:mentionsumls-concept:C0206461lld:lifeskim
pubmed-article:14760324lifeskim:mentionsumls-concept:C0288672lld:lifeskim
pubmed-article:14760324lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:14760324lifeskim:mentionsumls-concept:C0427579lld:lifeskim
pubmed-article:14760324lifeskim:mentionsumls-concept:C0441509lld:lifeskim
pubmed-article:14760324lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:14760324lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:14760324pubmed:issue2lld:pubmed
pubmed-article:14760324pubmed:dateCreated2004-2-4lld:pubmed
pubmed-article:14760324pubmed:abstractTextIn acute coronary syndromes, the inflammation and the coagulation systems are activated, implying an impaired outcome. In addition to platelet inhibition, recent evidence suggests that the glycoprotein IIb/IIIa receptor inhibitor abciximab attenuates inflammation and coagulation activity.lld:pubmed
pubmed-article:14760324pubmed:languageenglld:pubmed
pubmed-article:14760324pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:citationSubsetAIMlld:pubmed
pubmed-article:14760324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14760324pubmed:statusMEDLINElld:pubmed
pubmed-article:14760324pubmed:monthFeblld:pubmed
pubmed-article:14760324pubmed:issn1097-6744lld:pubmed
pubmed-article:14760324pubmed:authorpubmed-author:SimoonsMaarte...lld:pubmed
pubmed-article:14760324pubmed:authorpubmed-author:WallentinLars...lld:pubmed
pubmed-article:14760324pubmed:authorpubmed-author:SiegbahnAgnet...lld:pubmed
pubmed-article:14760324pubmed:authorpubmed-author:ArmstrongPaul...lld:pubmed
pubmed-article:14760324pubmed:authorpubmed-author:JamesStefan...lld:pubmed
pubmed-article:14760324pubmed:authorpubmed-author:BarnathanElli...lld:pubmed
pubmed-article:14760324pubmed:authorpubmed-author:CaliffRobertRlld:pubmed
pubmed-article:14760324pubmed:issnTypeElectroniclld:pubmed
pubmed-article:14760324pubmed:volume147lld:pubmed
pubmed-article:14760324pubmed:ownerNLMlld:pubmed
pubmed-article:14760324pubmed:authorsCompleteYlld:pubmed
pubmed-article:14760324pubmed:pagination267-74lld:pubmed
pubmed-article:14760324pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:meshHeadingpubmed-meshheading:14760324...lld:pubmed
pubmed-article:14760324pubmed:year2004lld:pubmed
pubmed-article:14760324pubmed:articleTitleActivation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy.lld:pubmed
pubmed-article:14760324pubmed:affiliationDepartment of Medical Sciences, Cardiology, Thoraxcenter, Academic Hospital, Uppsala, Sweden. stefan.james@akademiska.selld:pubmed
pubmed-article:14760324pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14760324pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:14760324pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:14760324pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:14760324pubmed:publicationTypeMulticenter Studylld:pubmed